Document Type: Article All Authors / Contributors: Kohlstadt I.; Wharton G. Language Note: English Unique Identifier: 842918683 Awards:
| Title | : | Clinician uptake of obesity-related drug information: A qualitative assessment using continuing medical education activities |
| Author | : | Kohlstadt I.; Wharton G. |
| Language | : | en |
| Rating | : | 4.90 out of 5 stars |
| Type | : | PDF, ePub, Kindle |
| Uploaded | : | Apr 12, 2021 |
Download Clinician uptake of obesity-related drug information: A qualitative assessment using continuing medical education activities - Kohlstadt I.; Wharton G. | ePub
Related searches:
Clinician uptake of obesity-related drug information: a
Clinician uptake of obesity-related drug information: A qualitative assessment using continuing medical education activities
(PDF) Clinician uptake of obesity-related drug information: A
RESEARCH Open Access Clinician uptake of obesity-related drug
Weight Reduction Medications and Programs - Medical Clinical
Inequalities in the uptake of weight management interventions in a
Obesity: Metabolic and Clinical Consequences - The Medical
New Insight into Adiponectin Role in Obesity and Obesity-Related
Obesity Linked to Protein Involved in Controlling Fatty Acid Uptake
Obesity-Related Hypertension: Epidemiology, Pathophysiology
Association of Obesity-Related Metabolic Disruptions With
Prevalence, Pathophysiology, and Impact of Obesity-Related
Adipose Tissue in Obesity-Related Inflammation and Insulin
Obesity-Related Glomerulopathy: Body Mass Index and
Obesity-related glomerulopathy: An emerging epidemic
Metabolic phenotype of male obesity-related secondary
Uptake of Aortic 18F-FDG Is Correlated with Low-Density
2431 703 3149 4515 1797 3602 3248 1237 4073 3340 2603 3841 4753 2011 3364 4767 4774 1434 2785 2559 3551
Jan 9, 2018 obesity, which is broadly defined as excess body weight for a given motor output associated with the ingestion, digestion, and absorption of food. And clinical outcomes have suggested that disease risk and mortalit.
Clinician uptake of obesity-related drug information: a qualitative assessment using continuing medical education activities.
Absence of 18 f‐fluorodeoxyglucose uptake using positron emission tomography/computed publish in clinical obesity related titles issue.
International journal of obesity is a multi-disciplinary forum for papers describing basic, clinical and applied studies of obesity and related disorders.
In the past two decades, numerous experimental and clinical studies have established the importance of inflammation and immunity in the development of obesity and its metabolic complications, including insulin resistance and type 2 diabetes mellitus. In this context, t cells orchestrate inflammatory processes in metabolic organs, such as the adipose tissue (at) and liver, thereby mediating.
A total of 35 co-expression modules were detected, two of which showed associations with obesity-related traits, mainly at baseline. Gene ontology (go) enrichment was found for these two clinical trait-associated modules. One module consisting of 129 genes was enriched for a variety of processes, including cellular homeostasis and immune responses.
Uptake is expressed as % of that observed with aβ preincubated with apoe3 (medium gray) in the absence of leptin (first set of columns). Inclusion of rap abolished uptake (gray stripe) and so did omission of apoe (white). Leptin induced a dose‐dependent increase in aβ uptake with a preference for apoe3 (medium gray) over apoe4 (light gray).
This article is the first in a 4-part series on the endocrine society’s clinical practice guideline on the pharmacological management of obesity. This section presents an overview of the topic and the rationale for use of pharmacotherapy for chronic weight management.
Background metabolically healthy obesity (mho) is a considerably controversial concept as it is considered a transitory condition towards the development of different pathologies (type 2 diabetes, insulin resistance, or cardiovascular disease). Mho is closely related to lifestyle and environmental factors. Epigenetics has become an essential biological tool to analyze the link between obesity.
An extreme consequence of obesity is its involvement in the development of a range of pathological alterations in ventricular morphology and function, a condition clinically termed as obesity cardiomyopathy (ocm).
Chronic obesity-related inflammation is thought to lead to insulin resistance and diabetes, changes in the liver or non-alcoholic fatty acid liver disease, and cancers. More research is needed to understand what triggers inflammation in some obese patients and to find new treatments.
Clinician uptake of obesity-related drug information: a qualitative assessment using continuing medical education activities ingrid kohlstadt1* and gerold wharton2 abstract background: medications necessary for disease management can simultaneously contribute to weight gain, especially in children.
In obesity, adipose tissue lipid uptake and storage are impaired. Ectopic fat infiltrates organs like the liver, kidney and pancreas. Beyond visceral obesity, accumulation of ectopic fat in muscle is a frequent occurrence, leading to adverse body composition phenotypes characterized by reduced muscle mass (sarcopenia) and reduced muscle density.
Obesity is associated with reduced adenosine triphosphate (atp) turnover in skeletal muscle, a condition that can impair muscle metabolism.
Background: a lack of agreement on definitions and terminology used for nutrition-related concepts and procedures limits the development of clinical nutrition practice and research.
Some smaller clinical trials have revealed some specific cyp enzyme alterations, but, unfortunately, the results are somewhat contradictory, and specific conclusions are thus difficult to draw. 123,124 for many drugs commonly used in obese patients to treat comorbidities, such as antidepressants, antidiabetics, statins, antihypertensives.
Clinicians’ knowledge of medication-related weight gain may lead them to overestimate the benefits of a drug in relation to its metabolic risks. The knowledge base of pediatricians appears comparable to their counterparts in adult medicine, even though metabolic drug effects in children have only become prevalent recently.
We identified seven obesity-related myths concerning the effects of small sustained increases in energy intake or expenditure, establishment of realistic goals for weight loss, rapid weight loss.
An audit of routine clinical data on obesity treatment in primary care context of trial participation could differ from uptake in routine clinical practice and some.
The results of this study postulate aba as a new preventive or therapeutic intervention to improve glycaemic control and decrease obesity related systemic inflammation in patients with chronic metabolic diseases. The researchers are planning to advance aba to phase ii clinical trials in prediabetic and type 2 diabetes patients later this year.
Learn about childhood obesity, risk factors, classes, and more. Youth between 2 and 19 years old were considered to have clinical obesity. Prescription weight loss medications either prevent the absorption of fat or suppress appet.
Jan 22, 2020 but clinical management of obese patients is often complicated whether we summarize known obesity-associated alterations in absorption,.
Mar 18, 2020 studies in obese mice and overweight humans found decreased expression levels of the protein, ehd2, in fat tissue.
Therefore, coding for obesity services is fundamentally a two-tiered system, where the first tier requires that the provider submit claims using appropriate codes and the second tier involves the practice-level issues of denial management and contract negotiation.
Comparison of bioelectrical impedance and bmi in predicting obesity-related medical conditions.
Explore mayo clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition. Your effort to overcome obesity is more likely to be successful if you follow strategies at home in addition to your formal treatment plan.
However, since obesity is highly correlated to the development of type 2 diabetes, the pathophysiological complications associated with diabetes also contributes to obesity related mortality. Obesity is the result of excess accumulation of body fat including both cutaneous and visceral adipose tissue.
Uptake for the evaluation of the development of atherosclerosis remains unclear. In this study, we thus evaluated a general population to investigate the relationship between aortic 18f-fdg uptake and clinical parameters in the development of atherosclerotic disease. Study subjects the study was conducted during a cancer-screening.
Obesity-related hypertension is associated with renal sodium retention and impaired pressure natriuresis. 52 obese humans and subjects with the metabolic syndrome tend to be relatively salt sensitive. 53, 54 increased renal tubular reabsorption of sodium has been attributed to increased sympathetic outflow to the kidney.
Overweight and obesity are linked to an increased risk of 13 types of cancer. See a diagram of the human body highlighting the organs or tissues at increased cancer risk, including the breast, colon and rectum, kidney, and liver.
Nov 18, 2020 the goal of obesity treatment is to reach and stay at a healthy weight. Able to comfortably eat or decreases the absorption of food and calories, or it does both.
From this group, 71 cases with adequate clinical information were studied. Because of the limited follow-up, newly diagnosed cases of obesity-related glomerulopathy from the year 2000 were excluded. Patient charts were reviewed for age, sex, race, and presenting clinical and laboratory features at the time of renal biopsy.
Ongoing clinical trials in china and the united states are investigating the potential role of intravenous ascorbic acid in reducing respiratory failure requiring mechanical ventilation in patients with sars-cov-2. In addition, ascorbic acid, zinc, and vitamin d are being studied for the prevention of sars-cov-2 infection.
The global epidemic of obesity is a major public health problem today. Obesity increases the risk of many chronic diseases, such as type 2 diabetes, coronary heart disease, and certain types of cancer, and is associated with lower life expectancy.
Mar 22, 2021 mental illness such as clinical depression, anxiety, and other mental disorders8,9 body pain and difficulty with physical functioning10.
For aetna's clinical policy on surgical management of obesity, see cpb 0157 indirect calorimetry (also known as oxygen uptake analysis; diagnostic study).
Jun 13, 2018 food and obesity are undoubtedly linked but the relation is complex. Intake, and absorption, and small mismatches with food consumption over a long eating is a major problem for human nutrition and clinical scienc.
Post Your Comments: